about
More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future HoldsNeuroinflammatory responses in diabetic retinopathyInfluence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer PatientsROS homeostasis and metabolism: a critical liaison for cancer therapyConsidering renal risk while managing cancer.ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in miceGenetic targeting of sprouting angiogenesis using Apln-CreER.Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trialDopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.Rapid optimization of drug combinations for the optimal angiostatic treatment of cancerDramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials.Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.Requirement of novel amino acid fragments of orphan nuclear receptor TR3/Nur77 for its functions in angiogenesisNeuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.Minimal change disease onset observed after bevacizumab administration.Differential function and regulation of orphan nuclear receptor TR3 isoforms in endothelial cells.Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathyBevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).Excess maternal glucocorticoids in response to in utero undernutrition inhibit offspring angiogenesis.The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.Arterial hypertension and cancer.Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancerVEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update.A safety evaluation of ranibizumab in the treatment of age-related macular degeneration.Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Complications of intravitreal injections in patients with diabetes.The Far Side of Vascular Injury: Nonconventional Vasoconstrictors, DNA-targeting Agents, and Agents Toxic to Vascular Smooth Muscle.The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.Anti-angiogenic agents in ovarian cancer: past, present, and future.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Novel Pathophysiological Mechanisms in Hypertension.Orphan Nuclear Receptor TR3/Nur77 is a Specific Therapeutic Target for Hepatic Cancers.Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinibHypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma.Slit2/Robo1 signaling is involved in angiogenesis of glomerular endothelial cells exposed to a diabetic-like environment.Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
P2860
Q26781662-7EF4C19D-D12A-4EC1-A8C4-9EF658724839Q26798351-204C35AE-D19C-40DC-8910-074C82776203Q28080163-EB9D18EE-DDBF-44E0-ACB2-81FCFEE486CAQ28080316-8BC7CCA3-BBE2-48DE-818E-35ED763AF4C7Q30234338-9E2DDB8B-FE69-4F55-91DF-1841C5BBD81FQ33423350-824F6B03-F06A-4125-B18E-8FB04B20A2CEQ33628246-3D488696-4881-4374-B1B8-6A83DDD4CE9CQ33757106-7BE8388E-5478-4B10-AEAE-EF9B7D86421AQ35023052-4C73B58B-4820-4C59-B364-FF1E8FC9CC10Q35187848-E033E686-4BDF-4D81-8AE9-16578BC6D539Q35625070-75072882-329B-4FBA-912A-D65754042BE8Q35757208-C8A384A3-E694-4384-9BCE-0E0DDBB3221CQ35979621-B9572FBF-7873-4D7F-BC08-7EAB2825C052Q36008274-AC72A94F-7F3E-49F9-AD3D-BD2CD857C47DQ36086593-EDFB0658-ADB1-4F16-8447-BBE1B310A0BDQ36414440-C599B6BC-0CB0-4A16-B393-F2DBF393DB63Q36489958-96A5E8CB-2B8A-480D-9CE5-E36F6BEB8B78Q36689167-08E3A4AA-8E83-43CB-9193-10759CED58D0Q36814082-C00A6522-5DEA-4455-B08C-5FA270048811Q36818306-64A3BB33-A68B-45B2-A69F-3209387DE314Q36867626-A56602E6-AD1A-4411-B600-9C6759A7FFBCQ37329315-018AA200-F7CD-4C20-BE38-ED50CB98ACE3Q37699300-B2E51CC3-BC88-430D-A3BF-AE3AC9D9526AQ37729290-7B6E18D4-AD7C-4B3F-A41C-CFDC069A1552Q38115762-7C979A81-F21F-4A09-B1C6-FC3C3595E14DQ38125964-04AC5105-75CF-41F6-8D1A-FBA0AFF7BAE9Q38148602-9CF49696-0BDB-437D-95A1-014BD03604EDQ38236770-0F7F55A0-7E91-40C7-A565-8D19B8E8C95DQ38259982-14E97E5C-5DA9-466A-965B-75BE015E2E49Q38261106-C136E0B5-3992-485B-9C2B-BDDA3CF0BA12Q38583684-48B2112E-5899-4E76-AF37-B63515FEE744Q38693025-9355F27F-BA7D-40C3-AEC2-6F49D5AFD8E4Q38872239-8ABAEB70-21AD-431D-B8D3-7CCA599715FBQ38989374-D82727F8-D308-42EA-B0EB-D367859A6AD2Q39040850-34FA9AA4-7A3B-452C-9FDE-AFDDB5EFD554Q40097630-F8D2F073-2290-4457-BB66-736CC6880390Q41304682-734CDD6D-DAC9-4057-A3B2-592D1373383CQ41573990-7B978873-AAEF-455B-A1D2-E5E50D7BD7CDQ47233538-EA8F4D62-2921-413F-B838-F2DE110A6BF8Q47593350-BBFF7BDD-B6E0-4BDC-866E-7A743472AB8A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF inhibition, hypertension, and renal toxicity
@en
VEGF inhibition, hypertension, and renal toxicity.
@nl
type
label
VEGF inhibition, hypertension, and renal toxicity
@en
VEGF inhibition, hypertension, and renal toxicity.
@nl
prefLabel
VEGF inhibition, hypertension, and renal toxicity
@en
VEGF inhibition, hypertension, and renal toxicity.
@nl
P2093
P2860
P1476
VEGF inhibition, hypertension, and renal toxicity
@en
P2093
Joseph P Grande
Nelson Leung
Vesna D Garovic
P2860
P2888
P304
P356
10.1007/S11912-012-0242-Z
P577
2012-08-01T00:00:00Z